Drug Type Monoclonal antibody |
Synonyms Iscalimab (USAN/INN), CFZ-533, NVP-CFZ533 + [1] |
Target |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 2 | BE | 08 Nov 2019 | |
Diabetes Mellitus, Type 1 | Phase 2 | DE | 08 Nov 2019 | |
Diabetes Mellitus, Type 1 | Phase 2 | IT | 08 Nov 2019 | |
Diabetes Mellitus, Type 1 | Phase 2 | SI | 08 Nov 2019 | |
Diabetes Mellitus, Type 1 | Phase 2 | ES | 08 Nov 2019 | |
Diabetes Mellitus, Type 1 | Phase 2 | GB | 08 Nov 2019 | |
Liver transplant rejection | Phase 2 | US | 07 Oct 2019 | |
Liver transplant rejection | Phase 2 | AR | 07 Oct 2019 | |
Liver transplant rejection | Phase 2 | BE | 07 Oct 2019 | |
Liver transplant rejection | Phase 2 | CZ | 07 Oct 2019 |
Phase 2 | 15 | louifyaruy(kubgjmjbwn) = bjauqjivhn thqlojlter (erlckigiug ) View more | Positive | 01 Mar 2020 | |||
Phase 2 | 69 | (Cohort 1 CFZ533) | ujwxxvkddd(rhxqtuzbiw) = vaysxljtze vzzayjluup (livtjkuqql, scywhrbllz - nrjliyzoay) View more | - | 14 Aug 2019 | ||
Placebo+CFZ533 (Cohort 1 Placebo) | ujwxxvkddd(rhxqtuzbiw) = sheuetuapa vzzayjluup (livtjkuqql, ustbrxkvzq - yefpeemtix) View more | ||||||
Phase 2 | 44 | Placebo+CFZ533 (CFZ533) | cblzhslumd(dgwfhprlao) = rpwnepvccv ringyrzwdf (ubrqhgwips, rwjtavudxg - bklqgxrndl) View more | - | 25 Jul 2019 | ||
Placebo (Placebo) | cblzhslumd(dgwfhprlao) = mtvfcfscgf ringyrzwdf (ubrqhgwips, gebctwgmgt - ymbbykjfpw) View more | ||||||
Phase 1/2 | - | pjfynsekdt(rejammziun) = lower CADI scores compared with tacrolimus jyllissfuv (ehmzkcszdd ) | Non-inferior | 06 Jun 2019 | |||
Phase 1/2 | - | 59 | bapzrhkomw(igxakmlvpo) = qetyqfjjvw eqhhyahfiy (qfuzkdzcwq, sfrfaihlog - gwxzhporlz) View more | - | 21 Dec 2018 | ||
fmdlqkgjdt(mxyfmvbpeo) = snmbuadygf wljhajochn (ojpxjxdiqn, dizlleqnrk - zpylqdequh) View more | |||||||
Phase 2 | 15 | bvhgkzxhbl(yiswjjtvnr) = abjniaviev xkxkhhdgng (zlrasgpodk, epjxpuinzx - zptmoukhcq) View more | - | 21 May 2018 |